FIELD: medicine, therapy, hematology.
SUBSTANCE: the present innovation deals with treating anemia of different genesis due to applying recombinant Epoietin Omega (EO) to obtain medicinal preparation for treating anemia in patients being insensitive to the action of Epoietin Alpha or Beta, or in those who have unfavorable side effects in case of injecting these epoietins. The present innovation provides efficient therapy of anemia without any side action.
EFFECT: higher efficiency of therapy.
15 cl, 26 dwg, 10 ex, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACOKINETIC AND PHARMACODYNAMIC MODELLING IN ADMINISTRATION OF ERYTHROPOIETIN | 2000 |
|
RU2248215C2 |
| PHORBOL ESTER COMPOSITIONS AND METHODS OF USING THEM FOR TREATING OR REDUCING DURATION OF CYTOPENIA | 2015 |
|
RU2730998C2 |
| PHARMACEUTICAL COMPOSITIONS OF ERYTHROPOIETIN | 2000 |
|
RU2225221C2 |
| COMPOSITIONS AND METHODS OF TREATING ANAEMIA | 2014 |
|
RU2705206C2 |
| USING LCAT FOR TREATING ANAEMIA AND RED BLOOD CELL DISORDERS | 2010 |
|
RU2576838C2 |
| COMBINED APPLICATION OF TRAPS OF GDF AND ERYTHROPOIETIN RECEPTOR ACTIVATORS FOR INCREASING ERYTHROCYTE CONTENT | 2010 |
|
RU2592670C2 |
| METHOD FOR CORRECTION OF ANEMIA IN ERYTHROCYTES TRANSFUSION DEPENDENT PATIENTS WITH BETA-THALASSEMIA | 2023 |
|
RU2820878C1 |
| APPLICATION OF STABILISERS OF HIF- ALPHA FOR INTENSIFICATION OF ERYTHROPOIESIS | 2004 |
|
RU2414214C2 |
| COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASE | 2011 |
|
RU2606853C2 |
| COMPOSITIONS AND METHODS FOR LOWERING TRIGLYCERIDES WITHOUT INCREASING LDL CHOLESTEROL IN INDIVIDUAL RECEIVING CONCOMITANT THERAPY | 2010 |
|
RU2519043C2 |
